{"nct_id":"NCT02747043","title":"Study to Assess if ABP798 is Safe & Effective in Treating Non Hodgkin Lymphoma Compared to Rituximab","status":"COMPLETED","status_verified_date":"2022-09","start_date":"2016-05-25","start_date_type":"ACTUAL","primary_completion_date":"2019-06-28","primary_completion_date_type":"ACTUAL","completion_date":"2019-06-28","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["AMGN"]}